 Bennie Lindeque
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prosthesis-Related Infections | 5 | 2019 | 98 | 1.200 |
Why?
| | Bone Neoplasms | 5 | 2014 | 265 | 1.170 |
Why?
| | Mycobacterium Infections, Nontuberculous | 3 | 2019 | 339 | 1.040 |
Why?
| | Wounds, Gunshot | 2 | 2025 | 258 | 0.990 |
Why?
| | Forensic Ballistics | 1 | 2025 | 1 | 0.940 |
Why?
| | Nontuberculous Mycobacteria | 2 | 2019 | 189 | 0.880 |
Why?
| | Hip Prosthesis | 3 | 2015 | 42 | 0.860 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2024 | 29 | 0.800 |
Why?
| | Sarcoma | 2 | 2021 | 207 | 0.790 |
Why?
| | Knee Joint | 3 | 2016 | 429 | 0.780 |
Why?
| | Soft Tissue Neoplasms | 1 | 2024 | 131 | 0.730 |
Why?
| | Nylons | 1 | 2022 | 24 | 0.730 |
Why?
| | Knee Prosthesis | 2 | 2014 | 28 | 0.720 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2015 | 183 | 0.700 |
Why?
| | Orthopedic Procedures | 2 | 2014 | 244 | 0.700 |
Why?
| | Suture Techniques | 1 | 2022 | 137 | 0.680 |
Why?
| | Nocardia Infections | 1 | 2021 | 11 | 0.680 |
Why?
| | Thoracic Wall | 1 | 2021 | 21 | 0.680 |
Why?
| | Prostheses and Implants | 2 | 2014 | 137 | 0.640 |
Why?
| | Tibial Fractures | 4 | 2010 | 73 | 0.640 |
Why?
| | Firearms | 1 | 2025 | 436 | 0.570 |
Why?
| | Fracture Fixation, Intramedullary | 2 | 2010 | 60 | 0.570 |
Why?
| | Carcinoma, Renal Cell | 1 | 2021 | 230 | 0.570 |
Why?
| | Tertiary Care Centers | 1 | 2019 | 195 | 0.540 |
Why?
| | Musculoskeletal Diseases | 1 | 2019 | 91 | 0.530 |
Why?
| | Osseointegration | 1 | 2018 | 60 | 0.520 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2014 | 376 | 0.510 |
Why?
| | Thermal Conductivity | 1 | 2016 | 4 | 0.500 |
Why?
| | Kidney Neoplasms | 1 | 2021 | 415 | 0.500 |
Why?
| | Cortical Bone | 1 | 2016 | 15 | 0.500 |
Why?
| | Cancellous Bone | 1 | 2016 | 22 | 0.500 |
Why?
| | Antitubercular Agents | 2 | 2019 | 208 | 0.490 |
Why?
| | Prosthesis Implantation | 1 | 2018 | 156 | 0.490 |
Why?
| | Surgical Wound Infection | 2 | 2024 | 329 | 0.490 |
Why?
| | Freezing | 1 | 2016 | 83 | 0.490 |
Why?
| | Fracture Fixation, Internal | 2 | 2010 | 214 | 0.460 |
Why?
| | Body Temperature | 1 | 2016 | 227 | 0.460 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1791 | 0.450 |
Why?
| | Tenosynovitis | 1 | 2015 | 11 | 0.440 |
Why?
| | Cryosurgery | 2 | 2014 | 46 | 0.420 |
Why?
| | Osteoarthritis, Hip | 1 | 2015 | 45 | 0.420 |
Why?
| | Artificial Limbs | 1 | 2018 | 214 | 0.410 |
Why?
| | Osteotomy | 3 | 2016 | 129 | 0.410 |
Why?
| | Carbon | 1 | 2014 | 176 | 0.400 |
Why?
| | Osteochondroma | 2 | 2010 | 10 | 0.390 |
Why?
| | Arthritis, Infectious | 1 | 2014 | 76 | 0.390 |
Why?
| | Staphylococcal Infections | 2 | 2008 | 393 | 0.390 |
Why?
| | Splints | 1 | 2013 | 14 | 0.390 |
Why?
| | Casts, Surgical | 1 | 2013 | 36 | 0.380 |
Why?
| | Skin Temperature | 1 | 2013 | 36 | 0.380 |
Why?
| | Bone Density | 1 | 2016 | 487 | 0.370 |
Why?
| | Terrorism | 1 | 2012 | 27 | 0.370 |
Why?
| | Tibia | 2 | 2016 | 176 | 0.370 |
Why?
| | Prosthesis Design | 4 | 2018 | 356 | 0.370 |
Why?
| | Muscle Neoplasms | 1 | 2012 | 9 | 0.360 |
Why?
| | Biomedical Research | 2 | 2011 | 719 | 0.360 |
Why?
| | Body Temperature Regulation | 1 | 2013 | 105 | 0.360 |
Why?
| | Humans | 37 | 2025 | 145783 | 0.340 |
Why?
| | Financial Support | 1 | 2011 | 18 | 0.340 |
Why?
| | Private Sector | 1 | 2011 | 50 | 0.340 |
Why?
| | Health Care Sector | 1 | 2011 | 26 | 0.340 |
Why?
| | Bone Cements | 1 | 2011 | 39 | 0.330 |
Why?
| | Social Change | 1 | 2010 | 16 | 0.320 |
Why?
| | Drug Implants | 1 | 2011 | 83 | 0.320 |
Why?
| | Risk Assessment | 3 | 2011 | 3752 | 0.310 |
Why?
| | Fibula | 1 | 2010 | 36 | 0.310 |
Why?
| | Triage | 1 | 2012 | 250 | 0.300 |
Why?
| | Bone Plates | 1 | 2010 | 81 | 0.290 |
Why?
| | Bone Nails | 1 | 2009 | 61 | 0.280 |
Why?
| | Anti-Bacterial Agents | 2 | 2011 | 1925 | 0.280 |
Why?
| | Orthopedics | 1 | 2011 | 175 | 0.280 |
Why?
| | Salvage Therapy | 1 | 2009 | 165 | 0.260 |
Why?
| | Education, Medical, Undergraduate | 1 | 2010 | 208 | 0.260 |
Why?
| | Tensile Strength | 2 | 2022 | 98 | 0.250 |
Why?
| | Extremities | 1 | 2008 | 142 | 0.250 |
Why?
| | Chondrosarcoma | 1 | 2007 | 17 | 0.250 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 740 | 0.250 |
Why?
| | Fractures, Comminuted | 1 | 2006 | 22 | 0.250 |
Why?
| | Embryo Research | 1 | 2006 | 1 | 0.240 |
Why?
| | Biotechnology | 1 | 2006 | 45 | 0.230 |
Why?
| | Hip Fractures | 1 | 2006 | 87 | 0.230 |
Why?
| | Femoral Artery | 1 | 2006 | 190 | 0.220 |
Why?
| | Liability, Legal | 1 | 2005 | 42 | 0.220 |
Why?
| | Malpractice | 1 | 2005 | 44 | 0.220 |
Why?
| | Cross Infection | 1 | 2007 | 260 | 0.220 |
Why?
| | Stem Cell Transplantation | 1 | 2006 | 189 | 0.220 |
Why?
| | Academic Medical Centers | 1 | 2008 | 554 | 0.210 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 251 | 0.210 |
Why?
| | Wound Healing | 2 | 2024 | 355 | 0.210 |
Why?
| | Models, Animal | 1 | 2025 | 392 | 0.200 |
Why?
| | Cadaver | 2 | 2022 | 311 | 0.200 |
Why?
| | Skin Transplantation | 1 | 2024 | 85 | 0.200 |
Why?
| | Cell Culture Techniques | 1 | 2006 | 375 | 0.200 |
Why?
| | Swine | 1 | 2025 | 826 | 0.190 |
Why?
| | Atherosclerosis | 1 | 2006 | 409 | 0.190 |
Why?
| | Colorado | 4 | 2019 | 4556 | 0.180 |
Why?
| | Delivery of Health Care | 1 | 2009 | 948 | 0.180 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1582 | 0.180 |
Why?
| | Tissue Scaffolds | 1 | 2024 | 221 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3916 | 0.180 |
Why?
| | Sutures | 1 | 2022 | 66 | 0.180 |
Why?
| | Tissue Engineering | 1 | 2006 | 438 | 0.170 |
Why?
| | Cryotherapy | 1 | 2021 | 21 | 0.170 |
Why?
| | Stem Cells | 1 | 2006 | 630 | 0.170 |
Why?
| | Thigh | 1 | 2021 | 48 | 0.170 |
Why?
| | Equipment Failure Analysis | 2 | 2013 | 124 | 0.170 |
Why?
| | Biomechanical Phenomena | 2 | 2022 | 860 | 0.170 |
Why?
| | Retrospective Studies | 4 | 2024 | 17330 | 0.160 |
Why?
| | Extracellular Matrix | 1 | 2024 | 563 | 0.160 |
Why?
| | Immunocompromised Host | 1 | 2021 | 202 | 0.150 |
Why?
| | Reoperation | 2 | 2014 | 637 | 0.150 |
Why?
| | Public Health Surveillance | 1 | 2019 | 83 | 0.140 |
Why?
| | Skin | 1 | 2024 | 754 | 0.140 |
Why?
| | Aged, 80 and over | 4 | 2019 | 8347 | 0.140 |
Why?
| | Risk Factors | 5 | 2014 | 10919 | 0.140 |
Why?
| | Middle Aged | 8 | 2021 | 36309 | 0.140 |
Why?
| | Aged | 6 | 2019 | 26217 | 0.140 |
Why?
| | Amputation Stumps | 1 | 2018 | 14 | 0.130 |
Why?
| | Symptom Assessment | 1 | 2019 | 136 | 0.130 |
Why?
| | Suture Anchors | 1 | 2018 | 35 | 0.130 |
Why?
| | Prosthesis Failure | 1 | 2018 | 125 | 0.130 |
Why?
| | Male | 10 | 2024 | 73010 | 0.130 |
Why?
| | Weight-Bearing | 1 | 2018 | 185 | 0.120 |
Why?
| | Amputees | 1 | 2018 | 100 | 0.120 |
Why?
| | Female | 11 | 2019 | 79045 | 0.120 |
Why?
| | Patellar Dislocation | 1 | 2016 | 8 | 0.120 |
Why?
| | Patellar Ligament | 1 | 2016 | 27 | 0.120 |
Why?
| | Patella | 1 | 2016 | 28 | 0.120 |
Why?
| | Tendon Transfer | 1 | 2016 | 24 | 0.120 |
Why?
| | Necrosis | 1 | 2016 | 244 | 0.110 |
Why?
| | Benzophenones | 1 | 2014 | 15 | 0.110 |
Why?
| | Femur | 1 | 2016 | 254 | 0.110 |
Why?
| | Internal Fixators | 1 | 2014 | 32 | 0.110 |
Why?
| | Ketones | 1 | 2014 | 50 | 0.100 |
Why?
| | Elasticity | 1 | 2014 | 189 | 0.100 |
Why?
| | Treatment Outcome | 3 | 2018 | 11794 | 0.100 |
Why?
| | Adult | 6 | 2024 | 40881 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3418 | 0.100 |
Why?
| | Healthy Volunteers | 1 | 2013 | 219 | 0.090 |
Why?
| | Prevalence | 2 | 2011 | 2875 | 0.090 |
Why?
| | Equipment Design | 1 | 2013 | 525 | 0.080 |
Why?
| | Research Support as Topic | 1 | 2011 | 81 | 0.080 |
Why?
| | Conflict of Interest | 1 | 2011 | 54 | 0.080 |
Why?
| | Incidence | 2 | 2008 | 2934 | 0.080 |
Why?
| | Polymers | 1 | 2014 | 485 | 0.080 |
Why?
| | Training Support | 1 | 2010 | 35 | 0.080 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 221 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2014 | 649 | 0.080 |
Why?
| | Thumb | 1 | 1990 | 37 | 0.070 |
Why?
| | Arthralgia | 1 | 2010 | 61 | 0.070 |
Why?
| | Patient Positioning | 1 | 2010 | 70 | 0.070 |
Why?
| | History, 20th Century | 1 | 2010 | 328 | 0.070 |
Why?
| | Europe | 1 | 2009 | 421 | 0.070 |
Why?
| | Methicillin Resistance | 1 | 2007 | 17 | 0.070 |
Why?
| | Arthroscopy | 1 | 2010 | 268 | 0.070 |
Why?
| | Young Adult | 2 | 2019 | 14254 | 0.070 |
Why?
| | Rare Diseases | 1 | 2008 | 116 | 0.060 |
Why?
| | United States | 3 | 2010 | 16126 | 0.060 |
Why?
| | Embolism, Fat | 1 | 1987 | 11 | 0.060 |
Why?
| | Osteoarthritis, Knee | 1 | 2010 | 281 | 0.060 |
Why?
| | Hospital Costs | 1 | 2007 | 125 | 0.060 |
Why?
| | Methylprednisolone | 1 | 1987 | 59 | 0.060 |
Why?
| | Prospective Studies | 2 | 2018 | 8078 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2011 | 1062 | 0.060 |
Why?
| | Intraoperative Complications | 1 | 2006 | 157 | 0.060 |
Why?
| | Hyphae | 1 | 2024 | 11 | 0.050 |
Why?
| | Fungi | 1 | 2024 | 121 | 0.050 |
Why?
| | Staphylococcus aureus | 1 | 2007 | 454 | 0.050 |
Why?
| | Biopsy | 1 | 2007 | 1082 | 0.050 |
Why?
| | Animals | 1 | 2025 | 38101 | 0.050 |
Why?
| | Fractures, Open | 1 | 2002 | 28 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2002 | 143 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 474 | 0.040 |
Why?
| | Adolescent | 3 | 2008 | 22577 | 0.020 |
Why?
| | Arthrodesis | 1 | 1990 | 36 | 0.020 |
Why?
| | Radiography | 1 | 1990 | 853 | 0.020 |
Why?
| | Complement C5 | 1 | 1987 | 33 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1987 | 154 | 0.010 |
Why?
| | Femoral Fractures | 1 | 1987 | 84 | 0.010 |
Why?
| | Random Allocation | 1 | 1987 | 365 | 0.010 |
Why?
| | Syndrome | 1 | 1987 | 381 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1990 | 1512 | 0.010 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2002 | 76 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2002 | 318 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1987 | 2064 | 0.010 |
Why?
| | Oxygen | 1 | 1987 | 981 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1368 | 0.010 |
Why?
|
|
Lindeque's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|